Abstract
This case–control study aims to investigate the role of HTERT MNS16A polymorphism as a potential risk factors and/or a prognostic marker for breast cancer. 113 consecutive incident cases of histologically confirmed ductal breast cancer and 124 healthy controls were recruited. HTERT MNS16A polymorphism was genotyped (L: long allele, S: short allele); multivariate logistic regression was performed. No significant association was noted either at the overall analysis (OR = 1.57, 95 % CI 0.84–2.93 for heterozygous LS carriers; OR = 1.02, 95 % CI 0.54–1.95 for homozygous SS carriers) or at the subanalyses in premenopausal and postmenopausal women. With respect to survival analysis, HTERT MNS16A polymorphism was not associated with either disease-free survival or overall survival. HTERT MNS16A polymorphism does not seem to be a risk factor for breast cancer in the Caucasian Greek population. Further, larger studies from other countries and subjects seem to be needed as this novel polymorphism is being examined in depth.
Similar content being viewed by others
References
Fang DH, Fan CH, Ji Q, Qi BX, Li J, Wang L (2012) Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies. Mol Biol Rep 39:6801–6809
Zhang Y, Huang M, Zhu Z (2012) AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non-carriers. Mol Biol Rep 39:6881–6886
Economopoulos KP, Sergentanis TN (2010) XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:439–443
He XF, Wei W, Li SX, Su J, Zhang Y, Ye XH, Liu Y, Wang W (2012) Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls. Mol Biol Rep (Epub ahead of print)
Sergentanis TN, Economopoulos KP (2010) Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 120:229–234
Economopoulos KP, Sergentanis TN (2010) Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis. Breast Cancer Res Treat 120:211–216
He BS, Pan YQ, Zhang Y, Xu YQ, Wang SK (2012) Effect of LEPR Gln223Arg polymorphism on breast cancer risk in different ethnic populations: a meta-analysis. Mol Biol Rep 39:3117–3122
Shen W, Cao X, Xi L, Deng L (2012) CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 39:2039–2044
Bollmann FM (2008) The many faces of telomerase: emerging extratelomeric effects. BioEssays 30:728–732
Deng Y, Chang S (2007) Role of telomeres and telomerase in genomic instability, senescence and cancer. Lab Invest 87:1071–1076
Dhaene K, Van Marck E, Parwaresch R (2000) Telomeres, telomerase and cancer: an up-date. Virchows Arch 437:1–16
Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33:787–791
Wang L, Soria JC, Chang YS, Lee HY, Wei Q, Mao L (2003) Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene 22:7123–7129
Wang Y, Hu Z, Liang J, Wang Z, Tang J, Wang S, Wang X, Qin J, Shen H (2008) A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women. Carcinogenesis 29:1197–1201
Jin G, Yoo SS, Cho S, Jeon HS, Lee WK, Kang HG, Choi YY, Choi JE, Cha SI, Lee EB, Kim CH, Jung TH, Kim YT, Park JY (2011) Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer. Cancer Sci 102:144–149
Zhang Y, Zhang H, Zhai Y, Wang Z, Ma F, Wang H, Li P, Zhang Y, Yu L, Cui Y, He F, Zhou G (2011) A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population. BMC Med 9:106
Hofer P, Baierl A, Feik E, Führlinger G, Leeb G, Mach K, Holzmann K, Micksche M, Gsur A (2011) MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer. Carcinogenesis 32:866–871
Carpentier C, Lejeune J, Gros F, Everhard S, Marie Y, Kaloshi G, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Sanson M (2007) Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol 84:249–253
Shen J, Gammon MD, Wu HC, Terry MB, Wang Q, Bradshaw PT, Teitelbaum SL, Neugut AI, Santella RM (2010) Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev 19:219–228
Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24:1291–1306
Rohlfs RV, Weir BS (2008) Distributions of Hardy–Weinberg equilibrium test statistics. Genetics 180:1609–1616
Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 12:477–488
Acknowledgments
A research grant has been received by HeSMO. FZ: is receiving a research grant from HeSMO.
Conflict of interest
The authors have declared no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zagouri, F., Sergentanis, T.N., Gazouli, M. et al. HTERT MNS16A polymorphism in breast cancer: a case–control study. Mol Biol Rep 39, 10859–10863 (2012). https://doi.org/10.1007/s11033-012-1982-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1982-4